BI-1241.20 Study – Sponsored by Boehringer Ingelheim Pharmaceutical

Completed Study

Ophthalmic exams only for Capital Digestive Care, which was participating in a Hepatitis C study.

Return to Sub-studies

Connect

Loading ...

Ophthalmologist Website Design | Accessibility Policy
BI-1241.20 STUDY | Capital Digestive Care in Washington | Capital Digestive Care Capitol Hill